Article: Klemtner adds new Nexium to roster of meds; Shop's success with Prilosec prompts move by AstraZeneca.(Brief Article)

AstraZeneca tapped Klemtner Advertising, New York, to handle the direct-to-consumer creative account for Nexium, the successor drug to its blockbuster heartburn treatment Prilosec.

Klemtner currently handles the heavily advertised Prilosec -- for which ads tagged "It's Prilosec time" feature the dominant image of raining purple pills -- and AstraZeneca felt the agency could help extend the so-called "purple reign."

"They've certainly performed very well" on Prilosec, a company spokesman said. "We wanted to give them the opportunity to do the same thing for Nexium."

The spokesman said Klemtner was awarded the business without a review. Grey ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!